Hemiacetal-less rapamycin derivatives designed and produced by genetic engineering of a type I polyketide synthase
2021 · Scientific Reports · 7 citations
https://doi.org/10.1038/s41598-021-88583-z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
141
Citations
2
h-index
1
i10-index
KEI KUDO is an academic researcher from Tohoku University. The author has contributed to research in topics: Heart Failure Treatment and Management & Receptor Mechanisms and Signaling & Hormonal Regulation and Hypertension. The author has an h-index of 2, co-authored 2 publications.
https://doi.org/10.1038/s41598-021-88583-z
https://doi.org/10.1186/s13256-018-1568-4
Click to start Chat